Financing
Debt Repayments
Bristol-Myers Squibb Debt Repayments decreased by 95.0% to $500.00M in Q1 2026 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Debt Repayments shows an upward trend with a 16.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryRisk
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Consistent repayment signals a strengthening balance sheet and a reduction in financial risk or leverage.
Detailed definition
The cash used to pay down the principal on outstanding loans, bonds, or commercial paper. This reduces the company's tot...
Peer comparison
Debt-heavy industries show high activity here; tech firms often use it to manage the maturity profile of their corporate bonds.
Metric ID:
debt_repaymentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00B | $500.00M | $0.00 | $5.77B | $2.88B | $2.79B | $0.00 | $1.64B | $239.00M | $0.00 | $2.00B | $0.00 | $395.00M | $2.48B | $0.00 | $0.00 | $643.00M | $229.00M | $10.07B | $500.00M |
| QoQ Change | — | -50.0% | -100.0% | — | -50.1% | -3.2% | -100.0% | — | -85.4% | -100.0% | — | -100.0% | — | +527.3% | -100.0% | — | — | -64.4% | >999% | -95.0% |
| YoY Change | — | — | — | — | +187.7% | +457.0% | — | -71.6% | -91.7% | -100.0% | — | -100.0% | +65.3% | — | -100.0% | — | +62.8% | -90.8% | — | — |
Range$0.00 – $10.07B
CAGR-13.6%
Avg YoY Growth+21.9%
Median YoY Growth-81.2%
Debt Repayments at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's debt repayments?
- Bristol-Myers Squibb (BMY) reported debt repayments of $500.00M in Q1 2026.
- What is the long-term trend for Bristol-Myers Squibb's debt repayments?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's debt repayments has grown at a 16.1% compound annual growth rate (CAGR), from $6.02B to $10.94B.
- What does debt repayments mean?
- The amount of money a company spent to pay back its borrowed debt.